BeautyHealth To Now Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

Rhea-AI Summary

The Beauty Health Company (NASDAQ:SKIN) delays reporting fourth quarter and full year 2023 financial results to March 12, 2024, due to additional preparation time required for the Annual Report filing. The Company will use the Form 12b-25 extension to file the Annual Report.

LONG BEACH, Calif.--(BUSINESS WIRE)-- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will now report fourth quarter and full year 2023 financial results on Tuesday, March 12, 2024, rather than on February 29, 2024, as initially announced. The Company will share results during an investor conference call and webcast at 4:30 p.m. ET on Tuesday, March 12, following a press release detailing the results.

A live webcast of the call can be accessed on the Company’s investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion.

The Company has determined that it is unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the year ended December 31, 2023 (the “Annual Report”) on February 29, 2024. Additional time is required for the Company to prepare the Annual Report and complete its customary closing process and review accounting procedures for the year ended December 31, 2023. As a result, the Company will file Form 12b-25 with the U.S. Securities and Exchange Commission on February 29, 2024, providing the Company a fifteen-day extension to file its Annual Report from the day such report was originally due.

Disclosure Information
The Beauty Health Company announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission, press releases, public conference calls and on its investor relations website (https://investors.beautyhealth.com) as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

About The Beauty Health Company
The Beauty Health Company (NASDAQ: SKIN) is a global category-creating company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful global community of estheticians, partners and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider, and learn more at beautyhealth.com or LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240229727950/en/

Investors: IR@beautyhealth.com

Press: press@beautyhealth.com

Source: The Beauty Health Company

FAQ

When will The Beauty Health Company report its fourth quarter and full year 2023 financial results?

The Beauty Health Company will report its fourth quarter and full year 2023 financial results on Tuesday, March 12, 2024, instead of February 29, 2024.

What time will the investor conference call and webcast take place?

The investor conference call and webcast will occur at 4:30 p.m. ET on Tuesday, March 12, 2024.

Where can the live webcast of the call be accessed?

The live webcast of the call can be accessed on The Beauty Health Company's investor relations website at https://investors.beautyhealth.com.

Why is The Beauty Health Company delaying the filing of its Annual Report on Form 10-K?

The Company needs additional time to prepare the Annual Report and complete its customary closing process and review accounting procedures for the year ended December 31, 2023.

What extension will The Beauty Health Company use to file its Annual Report?

The Company will utilize Form 12b-25 with the U.S. Securities and Exchange Commission, providing a fifteen-day extension to file the Annual Report from the original due date.